Date

Tuesday, 08 April 2014

Location

European Medicines Agency, Amsterdam, the Netherlands

The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.

Documents

Minutes of the COMP meeting 8-9 April 2014

COMP meeting report on the review of applications for orphan designation: April 2014

Agenda - COMP agenda of the 8-9 April 2014 meeting

How useful do you find this page?